Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,137–3,144 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Opus Genetics Inc. Nyxol Eye Drops - (MIRA-4) Mydriasis in patients aged 3-11 NDA Filing Ongoing Ophthalmic Opthalmic
Opus Genetics Inc. Nyxol + Low-Dose Pilocarpine Eye Drops - (VEGA-2/VEGA-3) Presbyopia Phase 3 Data Released Ophthalmic Opthalmic
Opus Genetics Inc. Nyxol Eye Drops - (LYNX-1) Dim Light or Night Vision Disturbances (DLD) Phase 3 Ongoing Ophthalmic Opthalmic
Opus Genetics Inc. Phentolamine ophthalmic solution - (LYNX-3) Decreased visual acuity under dim (mesopic) light conditions Phase 3 Data Released Ocular Opthalmic
Opus Genetics Inc. APX3330 Oral Pill - (ZETA-1) Diabetic Retinopathy (DR) / Macular Edema (DME) Phase 2/3 Trial Planned Oral Opthalmic
Oragenics Inc. AG013 Oral mucositis (OM) Phase 2 Oral rinse Wound Care
Organovo Holdings Inc. FXR314 MASH & Primary Biliary Cholangitis Phase 2/3 Data Released Topical Gastroenterology
Organovo Holdings Inc. FXR314 Ulcerative colitis (UC) Phase 2 Enrollment Initiation Topical Gastroenterology